Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Calcium. 2007 Nov;17(11):1727-30.

[Treatment of primary osteoporosis with vitamin K2].

[Article in Japanese]

Author information

  • National Center for Geriatrics and Gerontology, Department of Advanced Medicine.

Abstract

Menatetrenone (MK-4) is a form of vitamin K(2) (VK(2)) which is utilized for the treatment of osteoporosis. MK4 has a grade B as a total recommendation rate in the Japanese guideline for the prevention and treatment of osteoporosis in 2006 based on the current clinical evidences. The effects of fracture prevention by MK-4 are assumed to be based on the increase of bone mineral density as well as the improvement of bone quality. Recent researches suggest that VK affects bone metabolism via nuclear receptor in addition to the carboxylation of VK dependent proteins.

PMID:
17982193
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk